This review aims to synthesise qualitative research exploring determinants of self-management in adults with SMI, to inform the development of programmes to support self-management for people with both SMI and diabetes
Novo Nordisk submitted an NDA (new drug application) to the FDA on December 18, 2025, which is the formal step companies take when seeking approval for a medication to be marketed for public use
Yassine HN, Solomon V, Thakral A, Sheikh-Bahaei N, Chui HC, Braskie MN, Schneider LS, Talbot K (2022) Brain energy failure in dementia syndromes: opportunities and challenges for glucagon-like peptide-1 receptor agonists
As a consequence, vitamin B12 deficiency may develop in a breastfed infant within 36 months of age, severely affecting the baby's growth
We highlight several ongoing controversies in the field, and discuss the role of the microbiome in modulating the availability of NAD + precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), the presence of multiple cellular compartments that have distinct pools of NAD + and NADH, and non-canonical NAD + and NADH degradation pathways